The role of lncRNA H19 in tumorigenesis and drug resistance of human Cancers

Systemic therapy is one of the most significant cancer treatments. However, drug resistance often appears and has become the primary cause of cancer therapy failure. Regulation of drug target, drug metabolism and drug efflux, cell death escape (apoptosis, autophagy, et al.), epigenetic changes, and...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Xun Zhang, Mingpeng Luo, Jiahang Zhang, Bize Guo, Shreya Singh, Xixi Lin, Hanchu Xiong, Siwei Ju, Linbo Wang, Yulu Zhou, Jichun Zhou
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2022-09-01
coleção:	Frontiers in Genetics
Assuntos:	lncRNA H19 drug resistance tumorigenesis miRNA chemotherapy endocrine therapy
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fgene.2022.1005522/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!